Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation

by Michael D. Green

Book Overview

Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period...

• Format: Paperback
• Language: English
• ISBN: 0812216458
• ISBN13: 9780812216455
• Release Date: January 1998
• Publisher: University of Pennsylvania Press
• Length: 384 Pages
• Weight: 1.30 lbs.
• Dimensions: 0.8" x 5.9" x 8.9"